Bachem Holding Logo
CH0012530207
914589
BANB.SW

Bachem Holding

Loading quotes...

Forecast

There is no analyst data available for this company.


  • BACHEM: 10-year investment would have returned a 402.74% gain

    Ten years ago the BACHEM share closed at CHF 14.97; with the closing price of CHF 75.25 on 14 August 2026, an investment of CHF 10,000 would be worth CHF 50,274.35 today, equivalent to a gain of 402.74 percent. BACHEM's market capitalization was most recently CHF 5.63 billion. The calculation does not take stock splits and dividends into account. » More on finanzen.net


  • BACHEM surpasses analysts' expectations in H1 2026 thanks to expansion of production capacities

    BACHEM reports revenue of CHF 326.4m for the first half of 2026 (+4.3% or +7.3% in local currency) and a net profit of CHF 50.3m, beating estimates. EBITDA fell 9% to CHF 82.8m and the margin declined to 25.4%; charges arose from start‑up costs of the new "Gebäude K" plant in Bubendorf. BACHEM invested CHF 148.4m in H1 and confirms full‑year investments of CHF 350–400m as well as a revenue growth target of 35–40% for 2026. At full capacity of the new plants, a markedly better second half and an EBITDA margin in the low thirties in local currency are expected. Boris Corpataux will become chief commercial officer and a member of the corporate executive committee effective 1 August 2026. » More on finanzen.net


  • BACHEM: one-year return of 0.81% on a CHF 10,000 investment

    Someone who had invested CHF 10,000 in BACHEM stock a year ago would have CHF 10,080.59 today, representing an increase of 0.81%. The closing price is CHF 75.05 and the market capitalization is around CHF 5.62 billion. Stock splits and dividends are not included in the calculation. » More on finanzen.net

Historical dividends Dividends

All dividend metrics All metrics
In 2024, Bachem Holding has already paid +0,75 in dividends. The last payout was in April 2024.

Financials

In the last quarter, Bachem Holding had revenue of +353.66m and net profit of +54.46m
(EUR) Jun 2026
YoY
Revenue +353.66m -
Gross profit +88.46m -
Net profit +54.46m -
EBITDA +89.12m -

Fundamentals

Metric Value
Market capitalization
+6.09b
Number of shares
74.94m
52-week high/low
+88,85 - +51,78
Dividends No
Beta
0,8
P/E ratio
+38,24
PEG ratio
+3,42
P/B ratio
+3,95
P/S ratio
+8,05

Company profile

Die Bachem Holding AG liefert Produkte für die Forschung, die klinische Entwicklung und die kommerzielle Anwendung an Pharma- und Biotechnologieunternehmen weltweit. Das Unternehmen befasst sich mit der Entwicklung, Produktion und regulatorischen Unterstützung von peptidischen pharmazeutischen Wirkstoffen, wie Peptid- und Oligonukleotid-NCEs (New Chemical Entities). Darüber hinaus bietet es kommerzielle NCEs und Generika sowie Dienstleistungen in den Bereichen Projektmanagement, Qualität und Regulierung, Analytik, Produktion nach guter Herstellungspraxis, Produktion in Forschungsqualität sowie Lieferung und vertikale Integration an. Das Unternehmen wurde 1971 gegründet und hat seinen Hauptsitz in Bubendorf, Schweiz. Die Bachem Holding AG ist eine Tochtergesellschaft der Ingro Finanz AG.

Name
Bachem Holding
CEO
Anne-Kathrin Stoller
Headquarters Bubendorf, bl
Switzerland
Website
Sector
Health Care
Industry
Pharmaceuticals
IPO
07/17/1998
Employees 2.725

Ticker symbols

Exchange Symbol
SIX
BANB.SW
🍪

Parqet  uses cookies. Learn more